Dobesilic acid
As of the edition of 20 October 2026, Dobesilic acid is a small molecule: marketed, first approved in 1962 (CH).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2010
- Kind
- Small molecule
- Brand name
- Dicynone
- First approved
- 22 May 1962 (CH)
- Approvals on record
- 4 in 3 regions
- Holder of the most recent approval
- Apsen Farmaceutica; 3 holders in all
- Registered trials
- 15, 0 stopped early
- Disease areas
- Heart and blood vessels; Hormones; Pregnancy and women's health; Urinary and reproductive; Blood and lymph; Eye
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 0 | 0 | 0 |
| Phase 1 | 1 | 1 | 0 | 0 |
| Phase 2 | 2 | 1 | 0 | 0 |
| Phase 3 | 5 | 2 | 1 | 0 |
| Phase 4 | 5 | 2 | 1 | 0 |
| All trials | 15 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| OM Pharma | Applicant | 1962 to now |
| Apsen Farmaceutica | Applicant | 2010 to now |